Assessing Medicines for Use in the Geriatric Population-Reference-Cited by-同舟云学术

Assessing Medicines for Use in the Geriatric Population

Published:2022-11-27 Issue:3 Volume:113 Page:536-540
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Cerreta Francesca¹^ORCID,Vučić Katarina²,Laslop Andrea³

Affiliation:

1. Scientific Evidence Generation Department, European Medicines Agency (EMA) Amsterdam The Netherlands

2. Office of Therapies for Endocrine and Cardiovascular Diseases, Human Medicines Division European Medicines Agency Amsterdam The Netherlands

3. Scientific Office, Austrian Medicines and Medical Devices Agency Federal Office for Safety in Health Care Vienna Austria

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2793

Reference20 articles.

1. European Medicines Agency. Accessed August 25 2022.

2. European Medicines Agency. Accessed August 25 2022.

3. Issue Information

4. Examining the prevalence and correlates of multimorbidity among community-dwelling older adults: cross-sectional evidence from the Canadian Longitudinal Study on Aging (CLSA) first-follow-up data

5. Real‐world comparison of major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin;Lip G.Y.;Thromb. Haemost.,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potentially Inappropriate Medication: A Pilot Study in Institutionalized Older Adults;Healthcare;2024-06-26

2. New version of STOPP‑START criteria 2023. A suitable tool for drug prescribing optimization in older patients;Vnitřní lékařství;2023-12-18

3. Medication use quality and safety in older adults: 2022 update;Journal of the American Geriatrics Society;2023-12

4. Enhancing diversity of clinical trial populations in multiple sclerosis;Multiple Sclerosis Journal;2023-08

5. Prescribed Versus Taken Polypharmacy and Drug–Drug Interactions in Older Cardiovascular Patients during the COVID-19 Pandemic: Observational Cross-Sectional Analytical Study;Journal of Clinical Medicine;2023-08-01